FI924222A0 - Gp75 som ett tumoervaccin mot melanoma. - Google Patents
Gp75 som ett tumoervaccin mot melanoma.Info
- Publication number
- FI924222A0 FI924222A0 FI924222A FI924222A FI924222A0 FI 924222 A0 FI924222 A0 FI 924222A0 FI 924222 A FI924222 A FI 924222A FI 924222 A FI924222 A FI 924222A FI 924222 A0 FI924222 A0 FI 924222A0
- Authority
- FI
- Finland
- Prior art keywords
- fragment
- tumoervaccin
- mot
- melanoma
- stimulating
- Prior art date
Links
- 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 title 1
- 101000773083 Homo sapiens 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 title 1
- 201000001441 melanoma Diseases 0.000 title 1
- 239000012634 fragment Substances 0.000 abstract 4
- 229960005486 vaccine Drugs 0.000 abstract 3
- 125000003275 alpha amino acid group Chemical group 0.000 abstract 2
- 230000002708 enhancing effect Effects 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 230000004936 stimulating effect Effects 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 239000002299 complementary DNA Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y110/00—Oxidoreductases acting on diphenols and related substances as donors (1.10)
- C12Y110/03—Oxidoreductases acting on diphenols and related substances as donors (1.10) with an oxygen as acceptor (1.10.3)
- C12Y110/03001—Catechol oxidase (1.10.3.1), i.e. tyrosinase
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0055—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10)
- C12N9/0057—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10) with oxygen as acceptor (1.10.3)
- C12N9/0059—Catechol oxidase (1.10.3.1), i.e. tyrosinase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0071—Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/16—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with reduced pteridine as one donor, and incorporation of one atom of oxygen (1.14.16)
- C12Y114/16002—Tyrosine 3-monooxygenase (1.14.16.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y114/00—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
- C12Y114/18—Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with another compound as one donor, and incorporation of one atom of oxygen (1.14.18)
- C12Y114/18001—Tyrosinase (1.14.18.1)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US49743190A | 1990-03-22 | 1990-03-22 | |
| US49743190 | 1990-03-22 | ||
| US9101942 | 1991-03-22 | ||
| PCT/US1991/001942 WO1991014775A1 (en) | 1990-03-22 | 1991-03-22 | Gp75 as a tumor vaccine for melanoma |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| FI924222A0 true FI924222A0 (fi) | 1992-09-21 |
| FI924222A FI924222A (fi) | 1992-09-21 |
| FI113786B FI113786B (fi) | 2004-06-15 |
Family
ID=23976841
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI924222A FI113786B (fi) | 1990-03-22 | 1992-09-21 | gp75:tä koodaava eristetty nukleiinihappomolekyyli |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US6168946B1 (fi) |
| EP (2) | EP0965640A1 (fi) |
| JP (2) | JP3336006B2 (fi) |
| AT (1) | ATE187493T1 (fi) |
| AU (1) | AU660412B2 (fi) |
| CA (1) | CA2078773C (fi) |
| CZ (1) | CZ290278B6 (fi) |
| DE (1) | DE69131829T2 (fi) |
| DK (1) | DK0522078T3 (fi) |
| ES (1) | ES2141089T3 (fi) |
| FI (1) | FI113786B (fi) |
| GR (1) | GR3032804T3 (fi) |
| HK (1) | HK1014732A1 (fi) |
| HU (1) | HU218416B (fi) |
| IE (2) | IE910820A1 (fi) |
| NO (1) | NO311366B1 (fi) |
| NZ (1) | NZ237532A (fi) |
| PL (3) | PL169168B1 (fi) |
| PT (1) | PT97103B (fi) |
| SK (1) | SK282873B6 (fi) |
| WO (1) | WO1991014775A1 (fi) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE910820A1 (en) * | 1990-03-22 | 1991-09-25 | Sloan Kettering Inst Cancer | Gp75 as a tumor vaccine for melanoma |
| US7041801B1 (en) * | 1995-06-07 | 2006-05-09 | Vanderbilt University | Antibodies binding to polypeptides encoded by developmentally-regulated endothelial cell locus-1 |
| US7001600B1 (en) | 1996-02-09 | 2006-02-21 | The United States Of America As Represented By The Secretary Of Health And Human Services | Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes |
| US5840839A (en) * | 1996-02-09 | 1998-11-24 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein |
| US7015312B1 (en) | 1996-02-09 | 2006-03-21 | The United States Of America As Represented By The Department Of Health And Human Services | Antibodies to the protein product encoded by ORF3 of the TRP-1 gene and compositions and kits thereof |
| US6083703A (en) * | 1996-02-09 | 2000-07-04 | The United States Of America As Represented By The Department Of Health And Human Services | Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes |
| JP2004527449A (ja) * | 2000-02-15 | 2004-09-09 | リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | テロメラーゼ逆転写酵素を用いる癌を治療するための万能ワクチンと方法 |
| US6613534B2 (en) | 2001-03-20 | 2003-09-02 | Wake Forest University Health Sciences | MAP-2 as a determinant of metastatic potential |
| US20030113919A1 (en) * | 2001-08-17 | 2003-06-19 | Aventis Pasteur, Ltd. | Immunogenic targets for melanoma |
| US20030157720A1 (en) * | 2002-02-06 | 2003-08-21 | Expression Technologies Inc. | Protein standard for estimating size and mass |
| US20090117034A1 (en) | 2007-06-15 | 2009-05-07 | Nanhai Chen | Microorganisms for imaging and/or treatment of tumors |
| TWI384997B (zh) | 2008-03-12 | 2013-02-11 | Imclone Llc | 抗酪胺酸酶相關蛋白-１（ｔｙｒｐ１）抗體 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2504010B1 (fr) * | 1981-04-15 | 1985-10-25 | Sanofi Sa | Medicaments anticancereux contenant la chaine a de la ricine associee a un anticorps antimelanome et procede pour leur preparation |
| US4808704A (en) * | 1981-09-30 | 1989-02-28 | Sloan-Kettering Institute For Cancer Research | Monoclonal antibodies to cell surface antigens of human malignant melanoma |
| US4806628A (en) * | 1982-11-30 | 1989-02-21 | Sloan-Kettering Institute For Cancer Research | Monoclonal antibodies against melanocytes |
| US4591572A (en) * | 1983-04-01 | 1986-05-27 | Sloan-Kettering Institute For Cancer Research | Pigmentation associated, differentiation antigen of human melanoma and autologous antibody |
| USH819H (en) * | 1984-04-30 | 1990-09-04 | The United States Of America As Represented By The Secretary Of Energy | Palladium-109 labeled anti-melanoma monoclonal antibodies |
| US4851510A (en) * | 1984-11-30 | 1989-07-25 | Wadley Technologies, Inc. | Monoclonal antibodies to novel melanoma-associated antigens |
| US4798790A (en) * | 1985-07-18 | 1989-01-17 | Sloan-Kettering Institute | Monoclonal antibody specific for a pigmentation associated antigen |
| US5262177A (en) * | 1986-02-07 | 1993-11-16 | Oncogen | Recombinant viruses encoding the human melanoma-associated antigen |
| US5141742A (en) * | 1986-02-07 | 1992-08-25 | Oncogen | Vaccines against melanoma |
| US5009995A (en) * | 1986-10-27 | 1991-04-23 | Sloan-Kettering Institute For Cancer Research | Monoclonal antibodies to melanoma cells |
| US5059523A (en) * | 1988-05-02 | 1991-10-22 | Sloan-Kettering Institute For Cancer Research | Cell-surface glycoproteins of human sarcomas |
| US5009495A (en) * | 1989-05-26 | 1991-04-23 | Williams Robert D | Hinge for eyeglasses |
| EP0444181B2 (en) | 1989-08-04 | 2010-11-24 | Bayer Schering Pharma Aktiengesellschaft | C-erbb-2 external domain: gp75 |
| IE910820A1 (en) * | 1990-03-22 | 1991-09-25 | Sloan Kettering Inst Cancer | Gp75 as a tumor vaccine for melanoma |
| US5262117A (en) * | 1990-10-12 | 1993-11-16 | Centro Sviluppo Settori Impiego S.R.L. | Process for preparing thermoinsulating and/or structural formed articles and products so obtained |
| US6180604B1 (en) * | 1996-08-21 | 2001-01-30 | Micrologix Biotech Inc. | Compositions and methods for treating infections using analogues of indolicidin |
-
1991
- 1991-03-12 IE IE082091A patent/IE910820A1/en not_active IP Right Cessation
- 1991-03-12 IE IE20000918A patent/IE20000918A1/en not_active IP Right Cessation
- 1991-03-21 CZ CS1991760A patent/CZ290278B6/cs not_active IP Right Cessation
- 1991-03-21 PT PT97103A patent/PT97103B/pt not_active IP Right Cessation
- 1991-03-21 SK SK760-91A patent/SK282873B6/sk unknown
- 1991-03-21 NZ NZ237532A patent/NZ237532A/xx unknown
- 1991-03-22 PL PL91307930A patent/PL169168B1/pl not_active IP Right Cessation
- 1991-03-22 AU AU76906/91A patent/AU660412B2/en not_active Ceased
- 1991-03-22 AT AT91908003T patent/ATE187493T1/de not_active IP Right Cessation
- 1991-03-22 PL PL91307929A patent/PL169105B1/pl not_active IP Right Cessation
- 1991-03-22 PL PL91289550A patent/PL168235B1/pl not_active IP Right Cessation
- 1991-03-22 JP JP50783191A patent/JP3336006B2/ja not_active Expired - Fee Related
- 1991-03-22 HU HU9203009A patent/HU218416B/hu unknown
- 1991-03-22 DK DK91908003T patent/DK0522078T3/da active
- 1991-03-22 EP EP99109256A patent/EP0965640A1/en not_active Withdrawn
- 1991-03-22 ES ES91908003T patent/ES2141089T3/es not_active Expired - Lifetime
- 1991-03-22 DE DE69131829T patent/DE69131829T2/de not_active Revoked
- 1991-03-22 CA CA002078773A patent/CA2078773C/en not_active Expired - Fee Related
- 1991-03-22 WO PCT/US1991/001942 patent/WO1991014775A1/en not_active Application Discontinuation
- 1991-03-22 EP EP91908003A patent/EP0522078B1/en not_active Revoked
-
1992
- 1992-09-21 FI FI924222A patent/FI113786B/fi active
- 1992-09-21 NO NO19923659A patent/NO311366B1/no unknown
-
1995
- 1995-03-24 US US08/409,794 patent/US6168946B1/en not_active Expired - Lifetime
-
1998
- 1998-12-28 HK HK98116009A patent/HK1014732A1/xx not_active IP Right Cessation
-
2000
- 2000-02-29 GR GR20000400507T patent/GR3032804T3/el not_active IP Right Cessation
-
2001
- 2001-12-25 JP JP2001391870A patent/JP2002241314A/ja active Pending
-
2004
- 2004-06-25 US US10/877,489 patent/US20050037462A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL141868A0 (en) | Novel methods for therapeutic vaccination | |
| NO20022531L (no) | Vaksine for forebyggelse og behandling av Alzheimer- og amyloidrelaterte sykdommer | |
| HU9500571D0 (en) | Retro-, inverso-, and retro-inverso synthetic peptide analogues | |
| FI924222A (fi) | Gp75 som ett tumoervaccin mot melanoma | |
| RU2009130954A (ru) | Применение белков теплового шока для улучшения терапевтического эффекта невакционного лечебного воздействия | |
| HUP0302532A2 (hu) | Petefészekrák terápiájában és diagnosztizálásában alkalmazható készítmények és eljárások | |
| DE69435075D1 (de) | , die signalsequenzpeptide des endoplasmatischen reticulums und mindestens ein anderes peptid codieren, deren verwendung in impfstoffen und zur behandlung von krankheiten | |
| FI98217B (fi) | Menetelmä nekroositekijän valmistamiseksi | |
| RU2007142645A (ru) | Способ лечения или профилактики рака посредством использования композиций, содержащих альфа-2-макроглобулин | |
| DE69839273D1 (de) | Krebs immuntherapie mit semi-allogenen zellen | |
| DK0791064T3 (da) | Fremgangsmåde til forögelse af immunogeniciteten af en immunogen forbindelse eller et hapten og anvendelse heraf til fremstilling af vacciner | |
| HK1093314A1 (en) | Recombinant adenylate cyclase toxin of bordetella induces t cell responses against tumoral antigens | |
| DE69739385D1 (de) | Verbesserte impfstoffe | |
| EA200100395A1 (ru) | Фармацевтическая композиция, содержащая фрагменты днк, кодирующей антигенный белок, обладающая противоопухолевым действием | |
| WO1999065517A3 (en) | Therapeutic compositions that produce an immune response by altering the antigen | |
| EA200301125A1 (ru) | Вакцины, включающие в качестве адъюванта интерферон типа i, и связанные с этим способы | |
| EA200300638A1 (ru) | Вакцинная композиция, содержащая трансформирующий фактор роста альфа | |
| RU98112608A (ru) | Иммуногенная композиция [на основе] tlp | |
| HUP0003511A2 (hu) | Hepatitisz-B-vírus polipeptidek | |
| ATE177010T1 (de) | Immunverstärkung von impfstoffen, besonders von impfstoffen gegen schweinepleuropneumonie | |
| CY1108790T1 (el) | Συνθεσεις για τη θεραπεια και διαγνωση ωοθηκικου καρκινου |